["{\n\"step_by_step_thinking\": \"Based on the given patient profile, we can identify that HDL (High-Density Lipoprotein) is significantly lower than normal. This information suggests that the patient has low serum levels of HDL-cholesterol. According to the study 'High density lipoproteins in ischaemic heart disease', high-density lipoprotein cholesterol concentrations were significantly lower in ischaemic heart disease patients than in healthy subjects when age and sex-matched, which is the case here. This finding suggests that fenofibrate may be beneficial for this patient as it specifically targets low HDL levels.\",\n\"answer_choice\": \"B: Fenofibrate alone\""]